Nvidia is spending more than ever on Washington lobbying. It may not stop Congress from limiting China chip sales now.

Sens. Angela Alsobrooks and Ron Wyden are asking what steps the Department of Health and Human Services has taken to mitigate risks from the markets.

A Bernstein analyst thinks two key investor concerns will soon subside.

A Baird analyst no longer recommends buying the chip maker’s stock as its problems mount.

The rise in home-buying help from employers “speaks volumes about how difficult buying a home has become, even for people with steady jobs.”